Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Celltrion, Inc.

Capitalization 37,720B 24.25B 21B 19.27B 18.13B 33.76B 2,311B 34.29B 229B 89.13B 1,117B 91.04B 89.06B 3,886B P/E ratio 2026 *
29x
P/E ratio 2027 * 23.8x
Enterprise value 39.76B 25.56M 22.14M 20.31M 19.11M 35.59M 2.44B 36.15M 241M 93.96M 1.18B 95.97M 93.88M 4.1B EV / Sales 2026 *
7.47x
EV / Sales 2027 * 6.31x
Free-Float
53.67%
Yield 2026 *
0.42%
Yield 2027 * 0.44%
1 day-2.89%
1 week-6.70%
Current month-6.70%
1 month-11.13%
3 months-15.31%
6 months-1.82%
Current year-0.57%
1 week 169,900
Extreme 169900
182,571.43
1 month 169,523.81
Extreme 169523.8095
192,380.95
Current year 169,523.81
Extreme 169523.8095
239,047.62
1 year 150,571.43
Extreme 150571.4286
239,047.62
3 years 114,250.83
Extreme 114250.8285
239,047.62
5 years 114,250.83
Extreme 114250.8285
247,058.06
10 years 61,908.65
Extreme 61908.6518
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 50 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap.
01-15Sell 1,000 0.0004%
01-15Sell 1,000 0.0004%
01-15Sell 500 0.0002%
Change 5d. change 1-year change 3-years change Capi.($)
-2.89%-6.70%+14.76%+15.33% 24.25B
-0.50%-2.44%-16.04%-16.25% 42.68B
-4.15%-5.24%+263.18%+454.55% 31.73B
-1.84%+0.68%+20.44%-12.04% 30.62B
-3.51%-6.19%+5.57%+20.37% 30.03B
-0.55%+4.36%+10.28%+5.08% 13.17B
-3.83%-6.10% - - 13.07B
-0.97%+1.60%+53.20%+104.39% 12.97B
-0.87%-2.64%+111.05%+83.67% 12.31B
-2.19%+9.83%+7.43%-33.95% 11.44B
Average -1.78%-1.38%+52.21%+69.02% 22.23B
Weighted average by Cap. -1.73%-2.46%+53.03%+78.42%

Financials

2026 *2027 *
Net sales 5,323B 3.42B 2.96B 2.72B 2.56B 4.76B 326B 4.84B 32.32B 12.58B 158B 12.85B 12.57B 548B 6,170B 3.97B 3.43B 3.15B 2.97B 5.52B 378B 5.61B 37.46B 14.58B 183B 14.89B 14.57B 636B
Net income 1,403B 902M 781M 716M 674M 1.26B 85.92B 1.28B 8.52B 3.31B 41.55B 3.39B 3.31B 145B 1,689B 1.09B 940M 863M 812M 1.51B 103B 1.54B 10.26B 3.99B 50.05B 4.08B 3.99B 174B
Net Debt 2,044B 1.31B 1.14B 1.04B 982M 1.83B 125B 1.86B 12.41B 4.83B 60.54B 4.93B 4.83B 211B 1,186B 762M 660M 606M 570M 1.06B 72.64B 1.08B 7.2B 2.8B 35.13B 2.86B 2.8B 122B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
Date Price Change Volume
26-06-05 171,400.00 -2.89% 603,099
26-06-04 176,500.00 -1.37% 581,517
26-06-02 178,952.38 -1.98% 742,728
26-06-01 182,571.43 -0.62% 901,906
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
171,400.00KRW
Average target price
252,207.11KRW
Spread / Average Target
+47.15%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW